Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/57928
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAslan, Halil Serdar-
dc.contributor.authorArslan, Muhammet-
dc.contributor.authorAlver, Kadir Han-
dc.contributor.authorDemirci, Mahmut-
dc.contributor.authorKorkmaz, Mehmet-
dc.contributor.authorEsen, Kaan-
dc.contributor.authorTurmak, Mehmet-
dc.contributor.authorDeniz, Muhammed Akif-
dc.contributor.authorTekinhatun, Muhammed-
dc.contributor.authorKisbet, Tanju-
dc.contributor.authorArıbal, Serkan-
dc.contributor.authorÖnder, Hakan-
dc.contributor.authorOzdemir, Mustafa-
dc.contributor.authorOzturk, Mehmet H-
dc.contributor.authorUrfalı, Furkan Erturk-
dc.date.accessioned2024-09-30T15:26:40Z-
dc.date.available2024-09-30T15:26:40Z-
dc.date.issued2024-
dc.identifier.issn0091-2751-
dc.identifier.issn1097-0096-
dc.identifier.urihttps://doi.org/10.1002/jcu.23795-
dc.identifier.urihttps://hdl.handle.net/11499/57928-
dc.description.abstractPurposeTo investigate whether patients undergoing percutaneous liver mass biopsy (PLMB) can be safely discharged following a two-hour monitoring period.MethodsA multi-center prospective analysis was conducted for 375 patients (196 males and 179 females), mean age 63 +/- 12.45 years (range 37-89) who underwent PLMB between August 2023 and March 2024. Patients were monitored for 24 h, and complications were classified as minor or major. The timing of complications was categorized into three groups: within the first two hours, between the 2nd and 24th hours, and within 1 week after 24 hours.ResultsMinor complications occurred in 18.93% (71/375) and major complications in 2.13% (8/375). Most minor complications (80.2%, 57/71) appeared within the first two hours, 12.7% (9/71) between 2 and 24 h, and 7.1% (5/71) after 24 h. All major complications (62.5%, 5/8) except late-onset cases, occurred within the first two hours. No major complications occurred between 2 and 24 h. Late-onset major complications occurred in 37.5% (3/8) after 24 h.ConclusionThe two-hour monitoring period did not adversely impact patient management regarding minor complications and is safe for identifying all major complications except for late-onset ones. Extending the post-biopsy recovery period does not significantly improve patient care. A two-hour observation period after PLMB, including hemogram monitoring and ultrasound, does not adversely affect patient management regarding minor complications and is safe and efficient for detecting significant complications except delayed ones. Extending recovery time does not significantly improve patient care, as delayed complications appear later. imageen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of clinical ultrasounden_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectliver mass biopsy complicationsen_US
dc.subjectmonitorization timeen_US
dc.subjectNeedle-Biopsyen_US
dc.subjectRecovery-Timeen_US
dc.subjectRisk-Factorsen_US
dc.subjectComplicationsen_US
dc.subjectAuditen_US
dc.subjectRatesen_US
dc.subjectPainen_US
dc.titleIs a two-hour monitoring period sufficient and safe for patients undergoing ultrasound-guided percutaneous liver mass biopsy?: A prospective and multicenter experienceen_US
dc.typeArticleen_US
dc.typeArticle; Early Accessen_US
dc.departmentPamukkale Universityen_US
dc.authoridKorkmaz, Mehmet/0000-0001-6234-9484-
dc.authoridAlver, Kadir Han/0000-0002-4692-2401-
dc.authoridDemirci, Mahmut/0000-0001-8201-9618-
dc.authoridOZDEMIR, MUSTAFA/0000-0002-1934-5346-
dc.authoridArslan, Muhammet/0000-0001-5565-0770-
dc.authoridTekinhatun, Muhammed/0000-0002-3240-6991-
dc.authoridDENIZ, Muhammed Akif/0000-0002-9586-2425-
dc.identifier.doi10.1002/jcu.23795-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57226492427-
dc.authorscopusid35274490400-
dc.authorscopusid57208031154-
dc.authorscopusid57203169007-
dc.authorscopusid57210381412-
dc.authorscopusid55319312100-
dc.authorscopusid56204419100-
dc.authorwosiddemirci, mahmut/AAB-2132-2021-
dc.authorwosidTekinhatun, Muhammed/ABH-3497-2021-
dc.authorwosidOZDEMIR, MUSTAFA/HJZ-1646-2023-
dc.authorwosidKorkmaz, Mehmet/ISU-6883-2023-
dc.identifier.pmid39225264en_US
dc.identifier.scopus2-s2.0-85202918561en_US
dc.identifier.wosWOS:001303363900001en_US
dc.institutionauthor-
item.cerifentitytypePublications-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeArticle-
item.openairetypeArticle; Early Access-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextNo Fulltext-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept39.04. Architecture and Urban Planning-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.